Also trades as: PRM.L (LSE) · $vol 0M
PMSNF OTC
Proteome Sciences plc
1W: +0.0%
1M: +0.0%
3M: -50.0%
YTD: -75.0%
1Y: -80.0%
3Y: -99.1%
$0.01
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$826K
-71.7% ▼
Capital Expenditures
$224K
+5.5% ▲
5Y CAGR: -83.4%
Free Cash Flow
-$1M
-46.2% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+100.0% ▲
Net Change in Cash
-$899K
+54.3% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $295K | $72K | $1M | -$2M | -$3M |
| Depreciation & Amort. | $165K | $213K | $284K | $484K | $837K |
| Stock-Based Comp. | $8K | $570K | $303K | $218K | $40K |
| Change in Working Capital | $811K | -$328K | -$360K | $454K | $828K |
| Other Non-Cash Items | $304K | $477M | $513M | $806K | $875K |
| Operating Cash Flow | $2M | $793K | $2M | -$481K | -$826K |
| — Investing Activities — | |||||
| Capital Expenditures | -$1.3B | -$1.7B | -$1.7B | -$237K | -$224K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | -$17.1B | $6.0B | -$19.9B | -$187K | $0 |
| Investing Cash Flow | -$18.4B | $4.3B | -$21.7B | -$424K | -$224K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$146K | -$400K | -$209K | -$824K | $750K |
| Stock Repurchased | -$1.4B | -$1.7B | -$4.1B | -$5.2B | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $0 | $0 | -$238K | -$599K |
| Financing Cash Flow | -$146K | -$400K | -$209K | -$1M | $151K |
| Net Change in Cash | $43.5B | $49.1B | $19.6B | -$2M | -$899K |
| Cash End of Period | $210.1B | $259.2B | $278.8B | $2M | $1M |
| Free Cash Flow | -$9.1B | $8.8B | $2.1B | -$718K | -$1M |